# Itraconazole in Advanced Ovarian Cancer

> **NCT05591560** · NA · UNKNOWN · sponsor: **Tanta University** · enrollment: 66 (estimated)

## Conditions studied

- Ovarian Carcinoma

## Interventions

- **DRUG:** Itraconazole capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05591560
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2022-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05591560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05591560, "Itraconazole in Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05591560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*